Amyloid beta peptide 1-40 and the function of rat hippocampal hemicholinium-3 sensitive choline carriers: effects of a proteolytic degradation in vitro

. 2001 Mar ; 26 (3) : 203-12.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid11495543

Effects of amyloid beta peptide 1-40 (Abeta) and of plant cysteine proteases bromelain and papain on the high-affinity uptake of choline (HACU) and the specific binding of [3H]hemicholinium-3 ([3H]HC-3) have been investigated on hippocampal synaptosomes from young adult male Wistar rats under basal and stimulated conditions (55 mM KCl). Depolarization increased significantly the HACU levels (the changes were predominantly in Vmax) and mildly the [3H]HC-3 binding (the changes especially in K(D)). Nonaggregated Abeta at low nM concentrations suppressed the depolarization effects but was ineffective under basal conditions during a short-term incubation. Higher microM concentrations decreased the HACU and binding under basal conditions in a time-dependent manner. The binding changes were firstly associated with alterations in K(D) and secondarily were accompanied also by a drop in Bmax. The results suggest that Abeta directly influences high-affinity carriers, inhibits their transport activity and enhances their sensitivity to proteoLytic cleavage. Stimulation increases the sensitivity of carriers to the interaction with Abeta.

Zobrazit více v PubMed

Proc Natl Acad Sci U S A. 1990 Apr;87(7):2452-5 PubMed

Trends Neurosci. 1998 Jan;21(1):43-9 PubMed

J Neurochem. 1991 Sep;57(3):915-21 PubMed

J Neurochem. 1996 Mar;66(3):1113-7 PubMed

J Neurochem. 1998 Jan;70(1):210-5 PubMed

Biochem Biophys Res Commun. 1997 Apr 28;233(3):760-4 PubMed

Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6753-8 PubMed

J Neurochem. 1999 Aug;73(2):443-9 PubMed

Brain Res. 1999 Apr 3;824(1):89-96 PubMed

Neurochem Res. 1995 Aug;20(8):939-49 PubMed

J Neurochem. 1985 Jan;44(1):11-24 PubMed

J Pharmacol Exp Ther. 1990 Sep;254(3):1029-37 PubMed

Biochem J. 1994 May 15;300 ( Pt 1):107-10 PubMed

Prog Neurobiol. 1998 Dec;56(5):541-69 PubMed

Biochemistry. 1996 Jul 23;35(29):9407-14 PubMed

Brain Res. 1991 Jun 21;552(1):170-4 PubMed

J Neurochem. 1996 Oct;67(4):1774-7 PubMed

Biochem Biophys Res Commun. 1995 Aug 24;213(3):944-9 PubMed

J Neurochem. 1999 Oct;73(4):1626-34 PubMed

Neurosci Lett. 1997 Sep 26;234(1):71-3 PubMed

J Neurosci. 1990 Jan;10 (1):62-72 PubMed

J Neurochem. 1998 May;70(5):2179-87 PubMed

J Biol Chem. 1998 May 29;273(22):13379-82 PubMed

J Neurobiol. 1990 Mar;21(2):269-75 PubMed

Neurochem Res. 1998 Jul;23(7):923-9 PubMed

Alcohol Clin Exp Res. 1998 May;22(3):704-9 PubMed

Prog Neurobiol. 1998 Aug;55(6):659-69 PubMed

FEBS Lett. 1992 Jun 22;305(1):31-6 PubMed

Arch Gerontol Geriatr. 1993 Nov-Dec;17(3):179-88 PubMed

J Neurochem. 1983 Feb;40(2):503-9 PubMed

Alcohol Clin Exp Res. 1988 Feb;12(1):179-83 PubMed

Anal Biochem. 1976 May 7;72:248-54 PubMed

Neurosci Lett. 1998 Nov 27;257(2):93-6 PubMed

J Neurobiol. 1992 Mar;23(2):163-72 PubMed

Exp Gerontol. 1995 Mar-Apr;30(2):125-36 PubMed

J Neurosci. 1995 Sep;15(9):6239-49 PubMed

Biochem J. 1997 Oct 1;327 ( Pt 1):199-202 PubMed

J Neurochem. 1990 May;54(5):1500-8 PubMed

J Neurochem. 1994 Oct;63(4):1328-37 PubMed

Curr Opin Neurobiol. 1995 Oct;5(5):642-6 PubMed

Neurochem Res. 1997 Dec;22(12):1437-42 PubMed

J Neurochem. 1988 Jun;50(6):1759-64 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...